ATRI Pengajuan SEC - Atrion Corporation- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

CIK

701288

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Atrion Corporation

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

November 14, 2024	SC 13G/A	ATRI / Atrion Corporation / GLAZER CAPITAL, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Atrion Corporation (Name of Issuer) Common stock, Par Value $0.10 per share (Title of Class of Securities) 049904105 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic
September 9, 2024	SC 13G/A	ATRI / Atrion Corporation / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0090124-1sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 8)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) August 31, 2024 (Date o
September 3, 2024	15-12G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-082
August 22, 2024	SC 13D/A	ATRI / Atrion Corporation / Battat David A - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Atrion Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) David A. Battat, One Allentown Parkway, Allen, Texas 75002 (972) 390-9800 (Name, Address and Telephone Number of Person Authorized to Receive Notices
August 22, 2024	SC 13D/A	ATRI / Atrion Corporation / STUPP BROS INC - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Atrion Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) John P. Stupp, Jr., President, Stupp Bros., Inc., 3800 Weber Road, St. Louis, Missouri 63125 (314) 638-5000 (Name, Address and Telephone Number of Pe
August 22, 2024	SC 13D/A	ATRI / Atrion Corporation / BATTAT EMILE A - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Atrion Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) Emile A Battat, One Allentown Parkway, Allen, Texas 75002 (972) 390-9800 (Name, Address and Telephone Number of Person Authorized to Receive Notices
August 22, 2024	SC 13D/A	ATRI / Atrion Corporation / STUPP JOHN P JR - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Atrion Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) John P. Stupp, Jr., 3800 Weber Road, St. Louis, Missouri 63125 (314) 638-5000 (Name, Address and Telephone Number of Person Authorized to Receive Not
August 21, 2024	S-8 POS	As filed with the Securities and Exchange Commission on August 21, 2024 As filed with the Securities and Exchange Commission on August 21, 2024 Registration No.
August 21, 2024	EX-3.1	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ATRION CORPORATION Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ATRION CORPORATION FIRST: The name of the corporation is Atrion Corporation (the “Corporation”). SECOND: The address of its registered office in the State of Delaware is 251 Little Falls Drive, City of Wilmington, County of New Castle, Delaware 19808. The name of its registered agent at such address is Corporation Service Company. TH
August 21, 2024	SC 13D/A	ATRI / Atrion Corporation / NORDSON CORP - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* ATRION CORPORATION (Name of Issuer) COMMON STOCK, $0.10 PAR VALUE PER SHARE (Title of Class of Securities) 049904105 (CUSIP Number) Jennifer McDonough Executive Vice President, General Counsel and Secretary Nordson Corporation 28601 Clemens Ro
August 21, 2024	S-8 POS	As filed with the Securities and Exchange Commission on August 21, 2024 As filed with the Securities and Exchange Commission on August 21, 2024 Registration No.
August 21, 2024	S-8 POS	As filed with the Securities and Exchange Commission on August 21, 2024 As filed with the Securities and Exchange Commission on August 21, 2024 Registration No.
August 21, 2024	EX-3.2	AMENDED AND RESTATED BYLAWS OF ATRION CORPORATION * * * * * Article 1 Offices Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ATRION CORPORATION * * * * * Article 1 Offices Section 1.01. Registered Office. The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 1.02. Other Offices. The Corporation may also have offices at such other places both within and without the State of Delaware as the Board of Directors
August 21, 2024	S-8 POS	As filed with the Securities and Exchange Commission on August 21, 2024 As filed with the Securities and Exchange Commission on August 21, 2024 Registration No.
August 21, 2024	S-8 POS	As filed with the Securities and Exchange Commission on August 21, 2024 As filed with the Securities and Exchange Commission on August 21, 2024 Registration No.
August 21, 2024	S-8 POS	As filed with the Securities and Exchange Commission on August 21, 2024 As filed with the Securities and Exchange Commission on August 21, 2024 Registration No.
August 21, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 21, 2024 Atrion Corporatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 21, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction of incorporation) (Commission File
August 21, 2024	S-8 POS	As filed with the Securities and Exchange Commission on August 21, 2024 As filed with the Securities and Exchange Commission on August 21, 2024 Registration No.
August 20, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2024 Atrion Corporatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction of incorporation) (Commission File
August 9, 2024	EX-99.1	Atrion Reports Second Quarter 2024 Results EXHIBIT 99.1 Atrion Reports Second Quarter 2024 Results ALLEN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2024. Revenues for the second quarter of 2024 totaled $48.8 million compared to $43.8 million for the same period in 2023. For the just ended quarter, operating income was $0.5 million, down $6.8 m
August 9, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction of incorporation) (Commission File
August 9, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2024 Atrion Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction of incorporation) (Commission File
August 9, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Ex
August 9, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 Atrion Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File
July 26, 2024	SC 13G	ATRI / Atrion Corporation / GLAZER CAPITAL, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Atrion Corporation (Name of Issuer) Common Stock, $0.10 par value per share (Title of Class of Securities) 049904105 (CUSIP Number) July 17, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
July 15, 2024	DEFM14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi
July 2, 2024	PREM14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defi
July 2, 2024	SC 13G/A	ATRI / Atrion Corporation / Neuberger Berman Group LLC Passive Investment SC 13G/A 1 formsc13ga-07022024030742.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* ATRION CORP (Name of Issuer) Common (Title of Class of Securities) 049904105 (CUSIP Number) June 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p
July 2, 2024	EX-FILING FEES	Calculation of Filing Fee Table SCHEDULE 14A (Form Type) Atrion Corporation (Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Proposed Maximum Aggregate Value of Transaction Fee rate Amount of Filing Fee Fees to be Paid Exhibit 107 Calculation of Filing Fee Table SCHEDULE 14A (Form Type) Atrion Corporation (Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Proposed Maximum Aggregate Value of Transaction Fee rate Amount of Filing Fee Fees to be Paid $814,688,060.
May 31, 2024	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 0-10763 (State or other jurisdiction of incorporation) (Commission File Number) One Allentown Parkway, Allen, Texas 75002 (Address of principal executive offices) (Zip Code) Cindy Ferguson (972) 390 -9800 (N
May 31, 2024	EX-1.01	Atrion Corporation’s Conflict Minerals Report for the period January 1 to December 31, 2023. EXHIBIT 1.01 CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2023 I. Introduction This is the Conflict Minerals1 Report of Atrion Corporation (”we,” “our,” “us,” “Atrion,” or the “Company”) prepared for calendar year 2023 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “Act”). Numerous terms in this
May 30, 2024	EX-99.4	Form of Voting and Support Agreement. EX-99.4 5 d835225dex994.htm EX-4 Exhibit 4 FORM OF VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder of Atrion C
May 30, 2024	EX-99.2	Voting and Support Agreement, dated as of May 28, 2024, by and among Nordson Corporation and the Stockholders party thereto. EX-99.2 3 d835225dex992.htm EX-2 Exhibit 2 EXECUTION VERSION VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder o
May 30, 2024	SC 13D	ATRI / Atrion Corporation / NORDSON CORP - SC 13D Activist Investment SC 13D 1 d835225dsc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ATRION CORPORATION (Name of Issuer) COMMON STOCK, $0.10 PAR VALUE PER SHARE (Title of Class of Securities) 049904105 (CUSIP Number) Jennifer McDonough Executive Vice President, General Counsel and Secretary Nordson Corporation 28601 Clemen
May 30, 2024	EX-99.3	Voting and Support Agreement, dated as of May 28, 2024, by and among Nordson Corporation and the Stockholders party thereto. EX-99.3 4 d835225dex993.htm EX-3 Exhibit 3 EXECUTION VERSION VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder o
May 30, 2024	EX-99.1	Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc. and Atrion Corporation. EX-99.1 2 d835225dex991.htm EX-1 Exhibit 1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among NORDSON CORPORATION, ALPHA MEDICAL MERGER SUB, INC. and ATRION CORPORATION Dated as of May 28, 2024 TABLE OF CONTENTS Page ARTICLE I THE MERGER SECTION 1.01 The Merger 2 SECTION 1.02 Closing 2 SECTION 1.03 Effective Time 2 SECTION 1.04 Effects of the Merger 2 SECTION 1.05 Certificate of Incorpora
May 29, 2024	EX-2.1	Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Merger Sub, Inc. and Atrion Corporation. Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among NORDSON CORPORATION, ALPHA MEDICAL MERGER SUB, INC. and ATRION CORPORATION Dated as of May 28, 2024 TABLE OF CONTENTS Page Article I THE MERGER SECTION 1.01 The Merger 2 SECTION 1.02 Closing 2 SECTION 1.03 Effective Time 2 SECTION 1.04 Effects of the Merger 2 SECTION 1.05 Certificate of Incorporation and Bylaws of the Survivin
May 29, 2024	EX-99.1	Voting and Support Agreement, dated May 27, 2024, by and among Stupp Bros., Inc., John P. Stupp, Jr., and Nordson Corporation EX-99.1 2 tm2415826d4ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder of A
May 29, 2024	SC 13D	ATRI / Atrion Corporation / Battat David A - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.                            )* Atrion Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) David A. Battat, One Allentown Parkway, Allen, Texas 75002 (972) 390-9800 (Name, Address and Telephone Number of Person Aut
May 29, 2024	EX-10.2	Voting and Support Agreement, dated as of May 28, 2024, by and among Nordson Corporation, John P. Stupp, Jr. and Stupp Bros., Inc. Exhibit 10.2 EXECUTION VERSION VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder of Atrion Corporation, a Delawa
May 29, 2024	SC 13D/A	ATRI / Atrion Corporation / BATTAT EMILE A - SC 13D/A Activist Investment SC 13D/A 1 tm2415826d1sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Atrion Corporation (Name of Issuer) Common Shares (Title of Class of Securities) 049904105 (CUSIP Number) Emile A Battat One Allentown Parkway Allen, Texas 75002 (972) 390-9800 (Name, Address and Telephone Number
May 29, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction of incorporation) (Commission File Nu
May 29, 2024	SC 13D/A	ATRI / Atrion Corporation / STUPP BROS INC - SC 13D/A Activist Investment SC 13D/A 1 tm2415826d4sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Atrion Corporation (Name of Issuer) Common Shares (Title of Class of Securities) 049904105 (CUSIP Number) John P. Stupp, Jr. President Stupp Bros., Inc. 3800 Webber Road St. Louis, MO 63125 (314) 638-5000 (Name,
May 29, 2024	SC 13D/A	ATRI / Atrion Corporation / STUPP JOHN P JR - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Atrion Corporation (Name of Issuer) Common Shares (Title of Class of Securities) 049904105 (CUSIP Number) John P. Stupp, Jr. 3800 Weber Road St. Louis, MO 63125 (314) 638-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notices an
May 29, 2024	EX-99.1	Voting and Support Agreement, dated May 27, 2024, by and among Mr. Battat, Montclair Harbour, LLC, Emile A Battat and Nordson Corporation Exhibit 99.1 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder of Atrion Corporation, a Delaware corporation (th
May 29, 2024	EX-99.1	Voting and Support Agreement, dated May 27, 2024, by and among Mr. Stupp, Stupp Bros., Inc., and Nordson Corporation EX-99.1 2 tm2415826d3ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder of A
May 29, 2024	EX-99.1	Voting and Support Agreement, dated May 27, 2024, by and among Mr. Battat, David A. Battat, Montclair Harbour, LLC, and Nordson Corporation EX-99.1 2 tm2415826d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder of A
May 29, 2024	EX-10.1	Exhibit 10.1 Exhibit 10.1 EXECUTION VERSION VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (as the same may be amended from time to time in accordance with its terms, this “Agreement”), dated as of May 28, 2024, by and among the Persons listed on Schedule A (each a “Stockholder” and collectively, the “Stockholders”) in each such person’s capacity as a stockholder of Atrion Corporation, a Delawa
May 29, 2024	DFAN14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☐ Filed by a Party Other Than the Registrant ☒ Check the Appropriate Box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ☐ Definitive Pro
May 28, 2024	EX-99.1	ATRION CORPORATION ENTERS INTO MERGER AGREEMENT WITH NORDSON CORPORATION Exhibit 99.1 Atrion Corporation One Allentown Parkway Allen, TX 75002 NEWS RELEASE FOR IMMEDIATE RELEASE ATRION CORPORATION ENTERS INTO MERGER AGREEMENT WITH NORDSON CORPORATION Allen, TX., May 28, 2024 – Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nords
May 28, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2024 Atrion Corporation ( UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction of incorporation) (Commission File Nu
May 24, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: May 20, 2024 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
May 24, 2024	EX-3.1	Certificate of Amendment of Certificate of Incorporation Exhibit 3.1 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION Atrion Corporation, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY: FIRST: This Certificate of Amendment (the “Certificate of Amendment”) amends the Certificate of Incorporation of Atrion Corporation (the “Certificate of Inc
May 10, 2024	EX-99.1	Atrion Reports First Quarter 2024 Results EXHIBIT 99.1 Atrion Reports First Quarter 2024 Results ALLEN, Texas, May 10, 2024 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2024. Revenues for the first quarter of 2024 totaled $47.3 million compared to $40.0 million for the same period in 2023. For the just ended quarter, operating income was $3.1 million, down $1.3 mill
May 10, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (E
May 10, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Nu
April 9, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨   Preliminary Proxy Statement ¨   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨   Definitive Prox
April 9, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Def
March 20, 2024	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Def
February 29, 2024	EX-99.1	Atrion Reports Fourth Quarter And Full Year 2023 Results EXHIBIT 99.1 Atrion Reports Fourth Quarter And Full Year 2023 Results ALLEN, Texas, Feb. 29, 2024 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2023 and the full year 2023. For the fourth quarter of 2023 compared to the fourth quarter of 2022, revenues were $43.6 million, up $729 thousand, operating income was $6.7 millio
February 29, 2024	EX-4.1	Description of Atrion Corporation’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. + EXHIBIT 4.1 DESCRIPTION OF ATRION CORPORATION’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2023, Atrion Corporation. (“Atrion,” the “Company,” “we,” “us,” or “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, $0.10 par value per share (“
February 29, 2024	EX-21	Subsidiaries of Atrion Corporation as of December 31, 2022. + EXHIBIT 21 Subsidiaries of Atrion Corporation As of December 31, 2023 Subsidiary State of Incorporation Ownership Atrion Medical Products, Inc. Delaware 100% Halkey-Roberts Corporation Delaware 100% Quest Medical, Inc. Texas 100% AlaTenn Pipeline Company LLC Alabama 100% Atrion Leasing Company LLC Alabama 100%
February 29, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2024 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission Fi
February 29, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Exact nam
February 13, 2024	SC 13G/A	ATRI / Atrion Corporation / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0086862-9sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 7)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2023 (Date
February 12, 2024	SC 13G/A	ATRI / Atrion Corporation / Neuberger Berman Group LLC Passive Investment SC 13G/A 1 formsc13ga-02122024060255.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* ATRION CORP (Name of Issuer) Common (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru
December 28, 2023	EX-10.3	Reaffirmation Agreement dated as of December 21, 2023 by and among Atrion Corporation, certain Subsidiaries of Atrion Corporation and Wells Fargo Bank, National Association.* Exhibit 10.3 REAFFIRMATION AGREEMENT This REAFFIRMATION AGREEMENT (this “Agreement”), is entered into as of December 21 2023, by and among ATRION CORPORATION, a Delaware corporation (the “Borrower”), each of the undersigned Subsidiaries of the Borrower (the “Guarantors” and, together with the Borrower, the “Credit Parties”) and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association
December 28, 2023	EX-10.2	Amended and Restated Revolving Note dated as of December 21, 2023 by Atrion Corporation, as Borrower, in favor of Wells Fargo Bank, National Association, as Lender.* Exhibit 10.2 AMENDED AND RESTATED REVOLVING CREDIT NOTE December 21, 2023 FOR VALUE RECEIVED, the undersigned, ATRION CORPORATION, a Delaware corporation (the “Borrower”), promises to pay to WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association (the “Lender”), at the place and times provided in the Credit Agreement referred to below, the unpaid principal amount of all Revolving Cr
December 28, 2023	EX-10.1	Amended and Restated Credit Agreement dated as of December 21, 2023 by and between Atrion Corporation, as Borrower, and Wells Fargo Bank, National Association, as Lender.* Exhibit 10.1 $25,000,000 AMENDED AND RESTATED CREDIT AGREEMENT dated as of December 21, 2023 by and between ATRION CORPORATION, as Borrower, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Lender TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 SECTION 1.1 Definitions 1 SECTION 1.2 Other Definitions and Provisions 21 SECTION 1.3 Accounting Terms. 21 SECTION 1.4 UCC Terms 22 SECTION 1.5 References to
December 28, 2023	EX-10.6	Change in Control Agreement dated as of December 21, 2023 by and between Atrion Corporation and Cindy Ferguson.* Exhibit 10.6 CHANGE IN CONTROL AGREEMENT THIS CHANGE IN CONTROL AGREEMENT (the “Agreement”) is entered into as of the 21st day of December, 2023 (the “Effective Date”) by and between ATRION CORPORATION, a Delaware corporation (the “Company”), and CINDY FERGUSON (the “Executive”). W I T N E S S E T H: WHEREAS, the Executive is currently employed as the Vice President and Chief Financial Officer, Se
December 28, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: December 21, 2023 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Empl
November 7, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporatio
November 7, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 7, 2023	EX-99.1	Atrion Reports Third Quarter 2023 Results EXHIBIT 99.1 Atrion Reports Third Quarter 2023 Results ALLEN, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2023. Revenues for the third quarter of 2023 totaled $41.9 million compared to $44.6 million for the same period in 2022. For the quarter ended September 30, 2023, operating income was $4.1 mill
September 20, 2023	EX-99.1	ATRION CORPORATION ANNOUNCES ELECTION OF NEW DIRECTOR Exhibit 99.1 FOR IMMEDIATE RELEASE ATRION CORPORATION ANNOUNCES ELECTION OF NEW DIRECTOR ALLEN, Texas (September 20, 2023) (GLOBE NEWSWIRE) – Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Ba
September 20, 2023	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: September 20, 2023 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Emp
August 8, 2023	EX-99.1	Atrion Reports Second Quarter 2023 Results EXHIBIT 99.1 Atrion Reports Second Quarter 2023 Results ALLEN, Texas, Aug. 08, 2023 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2023. Revenues for the second quarter of 2023 totaled $43.8 million compared to $48.9 million for the same period in 2022. For the quarter ended June 30, 2023, operating income was $7.4 million, do
August 8, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Ex
August 8, 2023	EX-10.1	Second Amendment to Credit Agreement dated as of June 29, 2023 by and between Atrion Corporation, as Borrower, and Wells Fargo Bank, National Association, as Lender EXHIBIT 10.1 EXECUTION VERSION SECOND AMENDMENT TO CREDIT AGREEMENT SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of June 29, 2023, among ATRION CORPORATION, a Delaware corporation (the “Borrower”), the Subsidiary Guarantors (as defined in the Credit Agreement referred to below) party hereto and WELLS FARGO BANK, NATIONAL ASSOCIATION, as lender (the “Lender”). Unless otherwise
August 8, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Atrion Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2023 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File
May 25, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: May 22, 2023 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
May 25, 2023	EX-10.1	Atrion Corporation 2023 Annual Incentive Compensation Plan EX-10.1 3 tm2317025d1ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 ATRION CORPORATION 2023 ANNUAL INCENTIVE COMPENSATION PLAN 1. Purpose The purpose of the Atrion Corporation 2023 Annual Incentive Compensation Plan is to motivate and reward eligible officers and other employees of Atrion Corporation and its subsidiaries with financial incentives if they meet or exceed certain goals. The Plan is intended to
May 25, 2023	EX-3.1	Atrion Corporation Bylaws (As amended and restated on May 22, 2023) Exhibit 3.1 BYLAWS OF ATRION CORPORATION (As amended and restated on May 22, 2023) ARTICLE One STOCKHOLDERS MEETINGS 1.01 Fixing Record Date. (a) In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders, or any adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon whic
May 23, 2023	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 0-10763 (State or other jurisdiction of incorporation) (Commission File Number) One Allentown Parkway, Allen, Texas 75002 (Address of principal executive offices) (Zip Code) Cindy Ferguson (972) 390 -9800 (N
May 23, 2023	EX-10.1	Atrion Corporation’s Conflict Minerals Report for the period January 1 to December 31, 2022. EX-10.1 2 atriex101.htm ATRION CORPORATION CONFLICT MINERALS REPORT EXHIBIT 10.1 CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2022 I. Introduction This is the Conflict Minerals1 Report of Atrion Corporation (“we,” “our,” “us,” “Atrion,” or the “Company”) prepared for calendar year 2022 in accordance with Rule 13p-1 (“Rule 13p-1”) under the
May 8, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (E
May 8, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 Atrion Corporation (E UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Num
May 8, 2023	EX-99.1	Atrion Reports First Quarter 2023 Results EXHIBIT 99.1 Atrion Reports First Quarter 2023 Results ALLEN, Texas, May 08, 2023 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2023. Revenues for the first quarter of 2023 totaled $40.0 million compared to $47.1 million for the same period in 2022. For the quarter ended March 31, 2023, operating income was $4.5 million, down
April 10, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Def
April 10, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Stat
March 9, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: March 4, 2023 (Date of earliest event reported) Atrion Corporation UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: March 4, 2023 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
February 27, 2023	EX-21	Subsidiaries of Atrion Corporation as of December 31, 2022. + EXHIBIT 21 Subsidiaries of Atrion Corporation As of December 31, 2022 Subsidiary State of Incorporation Ownership Atrion Medical Products, Inc. Delaware 100 % Halkey-Roberts Corporation Delaware 100 % Quest Medical, Inc. Texas 100 % AlaTenn Pipeline Company LLC Alabama 100 % Atrion Leasing Company LLC Alabama 100 %
February 27, 2023	EX-4.A	Description of Atrion Corporation’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. + EXHIBIT 4A DESCRIPTION OF ATRION CORPORATION’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2022, Atrion Corporation.
February 27, 2023	EX-99.1	Atrion Reports Fourth Quarter and Full Year 2022 Results EXHIBIT 99.1 Atrion Reports Fourth Quarter and Full Year 2022 Results ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022. Revenues for the fourth quarter of 2022 totaled $42.9 million compared to $40.3 million for the same period in 2021. For the quarter ended December 31
February 27, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Exact nam
February 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 Atrion Corporat UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2023 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission Fi
February 14, 2023	SC 13G/A	ATRI / Atrion Corporation / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant
February 10, 2023	SC 13G/A	ATRI / Atrion Corporation / Neuberger Berman Group LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ATRION CORP (Name of Issuer) Common (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi
February 7, 2023	10-Q/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (
November 8, 2022	EX-99.1	Atrion Reports Third Quarter 2022 Results EXHIBIT 99.1 Atrion Reports Third Quarter 2022 Results ALLEN, Texas, Nov. 08, 2022 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2022. Revenues for the third quarter of 2022 totaled $44.6 million compared to $42.9 million for the same period in 2021. For the quarter ended September 30, 2022, operating income was $9.6 mill
November 8, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 8, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2022 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporatio
October 6, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: October 4, 2022 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employ
August 26, 2022	EX-99.1	ATRION CORPORATION ANNOUNCES CFO SUCCESSION PLAN Exhibit 99.1 ATRION CORPORATION ANNOUNCES CFO SUCCESSION PLAN ALLEN, TEXAS, August 25, 2022?Atrion Corporation. (NASDAQ: ATRI) today announced that its Board of Directors has approved a succession plan under which Cindy Ferguson, currently the Company?s Controller, will become the Company?s Vice President and Chief Financial Officer, Secretary, and Treasurer effective March 4, 2023, succeeding Jef
August 26, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: August 22, 2022 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employ
August 8, 2022	EX-99.1	Atrion Reports Second Quarter 2022 Results EXHIBIT 99.1 Atrion Reports Second Quarter 2022 Results ALLEN, Texas, Aug. 08, 2022 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the second quarter ended June 30, 2022. Revenues for the second quarter of 2022 totaled $48.9 million compared to $42.7 million for the same period in 2021. For the quarter ended June 30, 2022, operating income was $11.0 million, u
August 8, 2022	EX-10.1	Retirement Agreement between Atrion Corporation and Jeffery Strickland dated July 29, 2022 incorporated by reference to Form 10-Q for Atrion Corporation filed August 8, 2022 EXHIBIT 10.1 RETIREMENT AGREEMENT THIS RETIREMENT AGREEMENT (the ?Agreement?), dated July 29, 2022, by and between ATRION CORPORATION, a Delaware corporation (the ?Company?), and JEFFERY STRICKLAND (?Executive?). WITNESSETH: WHEREAS, Executive is currently employed by the Company and serves as an officer or director of the Company and its subsidiaries (the Company and all such subsidiaries are ref
August 8, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Ex
August 8, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2022 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File
June 27, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: June 21, 2022 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
May 25, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: May 24, 2022 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
May 24, 2022	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report SD 1 atrisd.htm FORM SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 0-10763 63-0821819 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Allentown Parkway, Allen, Texas 75002 (Address of prin
May 24, 2022	EX-1.01	Atrion Corporation’s Conflict Minerals Report for the period January 1 to December 31, 2021. EX-1.01 2 atriex101.htm ATRION CORPORATION CONFLICT MINERALS REPORT EXHIBIT 1.01 CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2021 I. Introduction This is the Conflict Minerals1 Report of Atrion Corporation (”we,” “our,” “us,” “Atrion,” or the “Company”) prepared for calendar year 2021 in accordance with Rule 13p-1 (“Rule 13p-1”) under the
May 9, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2022 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Num
May 9, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2022 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (E
May 9, 2022	EX-99.1	Atrion Reports First Quarter 2022 Results EXHIBIT 99.1 Atrion Reports First Quarter 2022 Results ALLEN, Texas, May 09, 2022 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the first quarter ended March 31, 2022. Revenues for the first quarter of 2022 totaled $47.1 million compared to $39.2 million for the same period in 2021. For the quarter ended March 31, 2022, operating income was $10.3 million, up
April 12, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEF 14A 1 tm223545-1def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (
April 12, 2022	DEFA14A	Your Vote Counts! ATRION CORPORATION 2022 Annual Meeting Vote by May 23, 2022 11:59 PM ET ATRION CORPORATION ONE ALLENTOWN PARKWAY ALLEN, TX 75002 D78084-P69385 You invested in ATRION CORPORATION and it’s time to vote! You have the right to vote on p DEFA14A 1 tm223545d2defa14a.htm DEFA14A Your Vote Counts! ATRION CORPORATION 2022 Annual Meeting Vote by May 23, 2022 11:59 PM ET ATRION CORPORATION ONE ALLENTOWN PARKWAY ALLEN, TX 75002 D78084-P69385 You invested in ATRION CORPORATION and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of prox
February 25, 2022	EX-4.A	Description of Atrion Corporation’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934. + EXHIBIT 4A DESCRIPTION OF ATRION CORPORATION?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2021, Atrion Corporation.
February 25, 2022	EX-13.1	Stock Performance Graph.+ EXHIBIT 13.1 Company/Index 2016 2017 2018 2019 2020 2021 Atrion Corporation $ 100.00 $ 125.29 $ 148.40 $ 151.60 $ 130.92 $ 145.24 Russell 2000 Index $ 100.00 $ 114.65 $ 102.02 $ 128.06 $ 153.62 $ 176.39 SIC Code Index $ 100.00 $ 128.63 $ 129.29 $ 155.54 $ 172.24 $ 181.32 The graph set forth above compares the total cumulative return for the five-year period ended December 31, 2021 on the Company's
February 25, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Exact nam
February 25, 2022	EX-99.1	Atrion Reports Fourth Quarter and Full Year 2021 Results EXHIBIT 99.1 Atrion Reports Fourth Quarter and Full Year 2021 Results ALLEN, Texas, Feb. 25, 2022 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2021 and the full year 2021. Revenues for the fourth quarter of 2021 totaled $40.3 million compared to $32.2 million for the same period in 2020. Net income for the fourth quarter
February 25, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2022 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission Fi
February 25, 2022	EX-21	Subsidiaries of Atrion Corporation as of December 31, 2021. + EXHIBIT 21 Subsidiaries of Atrion Corporation As of December 31, 2021 Subsidiary State of Incorporation Ownership Atrion Medical Products, Inc. Delaware 100% Halkey-Roberts Corporation Delaware 100% Quest Medical, Inc. Texas 100% AlaTenn Pipeline Company LLC Alabama 100% Atrion Leasing Company LLC Alabama 100%
February 14, 2022	SC 13G/A	ATRI / Atrion Corporation / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is
February 11, 2022	SC 13G/A	ATRI / Atrion Corporation / Neuberger Berman Group LLC - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ATRION CORP (Name of Issuer) Common (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed
November 8, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2021 Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission Fil
November 8, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporatio
November 8, 2021	EX-10.1	Form of Restricted Stock Unit Award Agreement under Atrion Corporation 2021 Equity Incentive Plan incorporated by reference to Exhibit 10.1 to Atrion Corporation Form 10-Q filed November 8, 2021. EXHIBIT 10.1 ATRION CORPORATION 2021 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT THIS AWARD AGREEMENT (the ?Agreement?) is made and entered into effective as of [DATE] by and between ATRION CORPORATION, a Delaware corporation (the ?Company?), and [NAME OF PARTICIPANT] (the ?Participant?), pursuant to the Atrion Corporation 2021 Equity Incentive Plan, as it may be amended or restate
November 8, 2021	EX-99.1	Atrion Reports Third Quarter Results EXHIBIT 99.1 Atrion Reports Third Quarter Results ALLEN, Texas, Nov. 08, 2021 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2021. Revenues totaled $42.9 million compared to $33.8 million for the same period in 2020. Net income for the third quarter of 2021 totaled $8.3 million, an increase of $1.1 million compared to $7.2
August 31, 2021	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: August 30, 2021 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employ
August 31, 2021	EX-99.1	Atrion Corporation ANNOunces election of new DIRECTOR Exhibit 99.1 Atrion Corporation One Allentown Parkway Allen, TX 75002 NEWS RELEASE FOR IMMEDIATE RELEASE Atrion Corporation ANNOunces election of new DIRECTOR ALLEN, Texas (August 30, 2021) ? Atrion Corporation (NASDAQ: ATRI) today announced the election of Maria Sainz as a director, effective immediately. Ms. Sainz brings to our Board over 20 years of medical device and management experience from
August 9, 2021	EX-99.1	Atrion Reports Second Quarter Results EXHIBIT 99.1 Atrion Reports Second Quarter Results ALLEN, Texas, Aug. 09, 2021 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2021, revenues totaled $42.7 million compared with $38.0 million for the same period in 2020. Net income for the second quarter of 2021 totaled $8.9 million as compared to $8.6 million for the same period in 2
August 9, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2021 ATRION CORP (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Number)
August 9, 2021	EX-10.2	Form of Common Stock Award Agreement under Atrion Corporation 2021 Equity Incentive plan incorporated by reference to Exhibit 10.2 to Atrion Corporation Form 10-Q filed August 9, 2021. EXHIBIT 10.2 ATRION CORPORATION 2021 EQUITY INCENTIVE PLAN COMMON STOCK AWARD AGREEMENT THIS AWARD AGREEMENT (the ?Agreement?) is made and entered into as of , 20 by and between ATRION CORPORATION, a Delaware corporation (the ?Company?), and (the ?Participant?) pursuant to the Atrion Corporation 2021 Equity Incentive Plan, as it may be amended or restated from time to time (the ?Plan?). Capitalize
August 9, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Ex
May 25, 2021	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Atrion Corporation (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 0-10763 63-0821819 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Allentown Parkway, Allen, Texas 75002 (Address of principal executive offices)
May 25, 2021	EX-1.01	Exhibit 1.01 Exhibit 1.01 CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2020 I. Introduction This is the Conflict Minerals1 Report of Atrion Corporation (?we,? ?our,? ?us,? ?Atrion,? or the ?Company?) prepared for calendar year 2020 in accordance with Rule 13p-1 (?Rule 13p-1?) under the Securities Exchange Act of 1934 (the ?Act?). Numerous terms in this
May 25, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: May 21, 2021 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
May 21, 2021	S-8	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 Atrion Corporation (Exact name of Registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Atrion Corporation (Exact name of Registrant as specified in its charter) Delaware 63-0821819 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) One Allentown Parkway Allen, Texas 75002 (Address of principal execut
May 10, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2021 ATRION CORP (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Number) (
May 10, 2021	EX-99.1	Atrion Reports First Quarter Results EXHIBIT 99.1 Atrion Reports First Quarter Results ALLEN, Texas, May 10, 2021 (GLOBE NEWSWIRE) - Atrion Corporation (Nasdaq - ATRI) today announced that revenues for the quarter ended March 31, 2021 were $39.2 million compared with $43.6 million for the first quarter of 2020. Net income in the current-year quarter totaled $7.7 million compared to $8.9 million in last year?s first quarter, with dilu
May 10, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2021 or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (E
April 7, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
April 7, 2021	DEF 14A	Atrion Corporation 2021 Equity Incentive Plan effective May 21,2021 incorporated by reference to Appendix A Definitive Proxy Statement of Atrion Corporation filed on April 7, 2021. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 1, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2021 ATRION CORP (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Numb
March 1, 2021	EX-10.N	First Amended and Restated Restricted Stock Unit Award Agreement between the Company and David A. Battat dated as of December 29, 2020 incorporated by reference to Exhibit 10n to Atrion Corporation Form 10-K filed March 1, 2021. EXHIBIT 10n FIRST AMENDED AND RESTATED RESTRICTED STOCK UNIT AWARD AGREEMENT THIS FIRST AMENDED AND RESTATED RESTRICTED STOCK UNIT AWARD AGREEMENT (the ?Agreement?) is made and entered into as of December 29, 2020, by and between ATRION CORPORATION, a Delaware corporation (the ?Company?), and DAVID A.
March 1, 2021	EX-4.A	Description of Atrion Corporation’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 + EXHIBIT 4a DESCRIPTION OF ATRION CORPORATION?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2020, Atrion Corporation.
March 1, 2021	10-K	Annual Report - ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Exact nam
March 1, 2021	EX-10.O	First Amended and Restated Restricted Stock Unit Award Agreement between the Company and Jeffery Strickland dated as of December 29, 2020 + EXHIBIT 10o FIRST AMENDED AND RESTATED RESTRICTED STOCK UNIT AWARD AGREEMENT THIS FIRST AMENDED AND RESTATED RESTRICTED STOCK UNIT AWARD AGREEMENT (the "Agreement") is made and entered into as of December 29, 2020, by and between ATRION CORPORATION, a Delaware corporation (the "Company"), and JEFFERY STRICKLAND (?Strickland").
March 1, 2021	EX-21	Subsidiaries of Atrion Corporation as of December 31, 2020 + EXHIBIT 21 Subsidiaries of Atrion Corporation As of December 31, 2020 Subsidiary State of Incorporation Ownership Atrion Medical Products, Inc. Delaware 100 % Halkey-Roberts Corporation Delaware 100 % Quest Medical, Inc. Texas 100 % AlaTenn Pipeline Company LLC Alabama 100 % Atrion Leasing Company LLC Alabama 100 %
March 1, 2021	EX-99.1	Atrion Reports Results for Fourth Quarter and Full Year 2020 EXHIBIT 99.1 Atrion Reports Results for Fourth Quarter and Full Year 2020 ALLEN, Texas, Feb. 26, 2021 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2020 revenues were $32.2 million compared to $34.5 million in the same period of 2019, net income was $7.4 million compared to $8.1 million in the prior year period, and diluted earnings per share w
March 1, 2021	EX-13.1	Stock Performance Graph + EXHIBIT 13.1 Company/Index 2015 2016 2017 2018 2019 2020 Atrion Corporation $ 100.00 $ 134.26 $ 168.21 $ 199.25 $ 203.54 $ 175.78 Russell 2000 Index $ 100.00 $ 121.31 $ 139.08 $ 123.76 $ 155.35 $ 186.36 SIC Code Index $ 100.00 $ 116.43 $ 144.67 $ 140.90 $ 169.11 $ 184.59 The graph set forth above compares the total cumulative return for the five-year period ended December 31, 2020 on the Company's
March 1, 2021	EX-10.Y	First Amendment to Credit Agreement by and between Atrion Corporation, as Borrower, and Wells Fargo Bank, National Association, as Lender, dated February 12, 2021+ EXHIBIT 10y FIRST AMENDMENT TO CREDIT AGREEMENT FIRST AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?), dated as of February 12, among ATRION CORPORATION, a Delaware corporation (the ?Borrower?), the Subsidiary Guarantors (as defined in the Credit Agreement referred to below) party hereto and WELLS FARGO BANK, NATIONAL ASSOCIATION, as lender (the ?Lender?).
March 1, 2021	EX-10.M	First Amended and Restated Restricted Stock Unit Award Agreement between the Company and Emile A Battat dated as of December 29, 2020 incorporated by reference to Exhibit 10m to Atrion Corporation Form 10-K filed March 1, 2021. EXHIBIT 10m FIRST AMENDED AND RESTATED RESTRICTED STOCK UNIT AWARD AGREEMENT THIS FIRST AMENDED AND RESTATED RESTRICTED STOCK UNIT AWARD AGREEMENT (the ?Agreement?) is made and entered into as of December 29, 2020, by and between ATRION CORPORATION, a Delaware corporation (the ?Company?), and EMILE A BATTAT (?Battat?).
February 11, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) December 31, 202 Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi
February 10, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* ATRION CORP (Name of Issuer) (Title of Class of Securities) (CUSIP Number) December 31, 2020 (Date of E Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* ATRION CORP (Name of Issuer) Common (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch
February 10, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 03)* ATRION CORP (Name of Issuer) (Title of Class of Securities) (CUSIP Number) January 31, 2021 (Date of Ev Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 03)* ATRION CORP (Name of Issuer) Common (Title of Class of Securities) 049904105 (CUSIP Number) January 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche
December 31, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: December 29, 2020 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Empl
November 9, 2020	10-Q	Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporatio
November 9, 2020	EX-99.1	Atrion Reports Third Quarter Results EXHIBIT 99.1 Atrion Reports Third Quarter Results ALLEN, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter ended September 30, 2020 revenues totaled $33.8 million compared with $38.9 million for the same period in 2019. Net income for the third quarter of 2020 totaled $7.2 million as compared to $9.6 million for the same period in
November 9, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 ATRION CORP (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
August 6, 2020	EX-99.1	Atrion Reports Second Quarter Results EXHIBIT 99.1 Atrion Reports Second Quarter Results ALLEN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2020, revenues totaled $38.0 million compared with $40.1 million for the same period in 2019. Net income for the second quarter of 2020 totaled $8.6 million as compared to $9.7 million for the same period in 2
August 6, 2020	10-Q	Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Ex
August 6, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2020 ATRION CORP (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 26, 2020	10-K/A	Annual Report - 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 001-32982 Atrion Co
May 22, 2020	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: May 21, 2020 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
May 20, 2020	EX-1.01	Exhibit 1.01 – Atrion Corporation’s Conflict Minerals Report for the period January 1 to December 31, 2019. Exhibit 1.01 CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2019 I. Introduction This is the Conflict Minerals1 Report of Atrion Corporation (”we,” “our,” “us,” “Atrion,” or the “Company”) prepared for calendar year 2019 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “Act”). Numerous terms in this
May 20, 2020	SD	- SPECIALIZED DISCLOSURE REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 0-10763 63-0821819 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Allentown Parkway, Allen, Texas 75002 (Address of principal executive offices)
May 15, 2020	CORRESP	- 1400 SHIPT TOWER • 420 20TH STREET NORTH • BIRMINGHAM, ALABAMA 35203 • 205.328.0480 • bakerdonelson.com B. G. Minisman, Jr. Direct Dial: 2000005.250.-8305 Direct Fax: 205488.3705 E-Mail Address:[email protected] May 15, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Ada D. Sarmento Ms. Suzanne Haye
May 7, 2020	EX-99.1	Atrion Reports First Quarter Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Atrion Reports First Quarter Results ALLEN, Texas, May 07, 2020 (GLOBE NEWSWIRE) - Atrion Corporation (Nasdaq - ATRI) today announced that revenues for the quarter ended March 31, 2020 were $43.6 million compared with $41.6 million for the same period in 2019. Net income in the current-year quarter totaled $8.9 million compared to $9.4 million in las
May 7, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2020 ATRION CORP (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I
May 7, 2020	10-Q	Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2020 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (E
April 6, 2020	DEF 14A	ATRI / ATRION Corp. DEF 14A - - DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permit
April 6, 2020	DEFA14A	ATRI / ATRION Corp. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
March 4, 2020	CORRESP	- 1400 WELLS FARGO TOWER • 420 20TH STREET NORTH • BIRMINGHAM, ALABAMA 35203 • 205.328.0480 • bakerdonelson.com B. G. Minisman, Jr. Direct Dial: (205) 250-8305 Direct Fax: (205) 488-3705 E-Mail Address:[email protected] March 4, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Ada D. Sarmento Ms. Suzan
March 2, 2020	EX-4.(A)	Description of Atrion Corporation’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 + Exhibit 4a DESCRIPTION OF ATRION CORPORATION’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of December 31, 2019, Atrion Corporation.
March 2, 2020	10-K	Annual Report - FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Exact nam
March 2, 2020	EX-13.1	Stock Performance Graph + Exhibit 13.1 Company/Index 2014 2015 2016 2017 2018 2019 Atrion Corporation $ 100.00 $ 113.10 $ 151.85 $ 190.25 $ 225.35 $ 230.21 Russell 2000 Index $ 100.00 $ 95.59 $ 115.95 $ 132.94 $ 118.30 $ 148.49 SIC Code Index $ 100.00 $ 106.07 $ 123.01 $ 154.51 $ 150.56 $ 179.58 The graph set forth above compares the total cumulative return for the five-year period ended December 31, 2019 on the Company’s
March 2, 2020	EX-21	Subsidiaries of Atrion Corporation as of December 31, 2018 + Exhibit 21 Subsidiaries of Atrion Corporation As of December 31, 2019 Subsidiary State of Incorporation Ownership Atrion Medical Products, Inc. Delaware 100% Halkey-Roberts Corporation Delaware 100% Quest Medical, Inc. Texas 100% AlaTenn Pipeline Company LLC Alabama 100% Atrion Leasing Company LLC Alabama 100% -68-
February 26, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2020 ATRION CORP (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Numb
February 26, 2020	EX-99.1	Atrion Reports Results for Fourth Quarter and Full Year 2019 EXHIBIT 99.1 Atrion Reports Results for Fourth Quarter and Full Year 2019 ALLEN, Texas, Feb. 26, 2020 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2019 revenues were $34.5 million compared to $34.9 million in the same period of 2018, net income was $8.1 million compared to $7.7 million in the prior year period, and diluted earnings per share w
February 13, 2020	SC 13G/A	ATRI / ATRION Corp. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ATRION CORP (Name of Issuer) Common (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche
February 11, 2020	CORRESP	- 1400 WELLS FARGO TOWER • 420 20TH STREET NORTH • BIRMINGHAM, ALABAMA 35203 • 205.328.0480 • bakerdonelson.com B. G. Minisman, Jr. Direct Dial: (205) 250-8305 Direct Fax: (205) 488-3705 E-Mail Address:[email protected] February 11, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Ada D. Sarmento Ms. S
February 10, 2020	SC 13G/A	ATRI / ATRION Corp. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 03)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) January 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which thi
February 10, 2020	SC 13G/A	ATRI / ATRION Corp. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th
January 14, 2020	CORRESP	- 1400 WELLS FARGO TOWER • 420 20TH STREET NORTH • BIRMINGHAM, ALABAMA 35203 • 205.328.0480 • bakerdonelson.com B. G. Minisman, Jr. Direct Dial: (205) 250-8305 Direct Fax: (205) 488-3705 E-Mail Address:[email protected] January 14, 2020 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Ada D. Sarmento Ms. Su
November 1, 2019	EX-99.1	Atrion Reports Third Quarter Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Atrion Reports Third Quarter Results ALLEN, Texas, Nov. 01, 2019 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter ended September 30, 2019 revenues totaled $38.9 million down slightly from $39.3 million for the same period in 2018. Net income for the third quarter of 2019 totaled $9.6 million compared to
November 1, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2019 ATRION CORP (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Numbe
November 1, 2019	10-Q	Quarterly Report - 10-Q ??? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2019 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corpor
August 7, 2019	EX-99.1	Atrion Reports Second Quarter Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Atrion Reports Second Quarter Results ALLEN, Texas, Aug. 07, 2019 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2019 revenues totaled $40.1 million compared with $38.8 million for the same period in 2018. Net income for the second quarter of 2019 totaled $9.7 million as compared to $8.
August 7, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 7, 2019 ATRION CORP (Exact Name of Registrant as Specified in Charter) Delaware 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
August 7, 2019	10-Q	Quarterly Report - FORM 10-Q ??? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2019 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation
July 8, 2019	SC 13G/A	ATRI / ATRION Corp. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) June 30, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S
May 29, 2019	EX-1.01	CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2018 EX-1.01 2 atriex101.htm UNDERWRITING AGREEMENT Exhibit 1.01 CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2018 I. Introduction This is the Conflict Minerals1 Report of Atrion Corporation (”we,” “our,” “us,” “Atrion,” or the “Company”) prepared for calendar year 2018 in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange A
May 29, 2019	SD	ATRI / ATRION Corp. SD - - SPECIALIZED DISCLOSURE REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 0-10763 63-0821819 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Allentown Parkway, Allen, Texas 75002 (Address of principal executive offices)
May 22, 2019	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: May 21, 2019 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
May 8, 2019	EX-99.1	Atrion Reports First Quarter Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Atrion Reports First Quarter Results ALLEN, Texas, May 08, 2019 (GLOBE NEWSWIRE) - Atrion Corporation (Nasdaq - ATRI) today announced revenues for the quarter ended March 31, 2019 were $41.6 million compared with $39.4 million in the same period in 2018. Net income in the current-year quarter totaled $9.4 million compared to $8.5 million in last year
May 8, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 8, 2019 Atrion Corporation (Exact Name of Registrant as Specified in Charter) DE 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.
May 8, 2019	10-Q	Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2019 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporation (E
May 8, 2019	EX-10.3	SEVERANCE PLAN Effective April 25, 2000 (As amended on March 11, 2019) EX-10.3 4 atriex103.htm SEVERANCE PLAN Exhibit 10.3 SEVERANCE PLAN Effective April 25, 2000 (As amended on March 11, 2019) 1. PURPOSE OF PLAN While Atrion Corporation (the “Company”) is of the view that its business provides an optimistic outlook for the Company’s future profitability and growth and while the Company has no present plans for any Extraordinary Event (as defined below), the Company
May 8, 2019	EX-10.2	Second Amended and Restated Employment Agreement for Chairman incorporated by reference to Exhibit 10.2 to Atrion Corporation Form 10-Q filed May 8, 2019. EX-10.2 3 atriex102.htm SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT Exhibit 10.2 SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of the 11th day of March, 2019 by and between Atrion Corporation, a Delaware corporation (the “Company”), and Emile A Battat (the “Executive”). W I T N E S S E T H: WHEREAS,
May 8, 2019	EX-10.1	Second Amended and Restated Change in Control Agreement for President and Chief Executive Officer incorporated by reference to Exhibit 10.1 to Atrion Corporation Form 10-Q filed May 8, 2019. EX-10.1 2 atriex101.htm SECOND AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT Exhibit 10.1 SECOND AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT THIS SECOND AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (the “Agreement”) is entered into as of the 11th day of March, 2019 (the “Effective Date”) by and between ATRION CORPORATION, a Delaware corporation (the “Company”) and DAVID A. BATTAT (the
May 8, 2019	EX-10.4	ATRION CORPORATION SHORT-TERM INCENTIVE COMPENSATION PLAN Effective January 1, 2013 (As last amended on March 11, 2019) EX-10.4 5 atriex104.htm ATRION CORPORATION SHORT-TERM INCENTIVE COMPENSATION PLAN Exhibit 10.4 ATRION CORPORATION SHORT-TERM INCENTIVE COMPENSATION PLAN Effective January 1, 2013 (As last amended on March 11, 2019) i ATRION CORPORATION SHORT-TERM INCENTIVE COMPENSATION PLAN Introduction Atrion Corporation (the “Corporation”) adopts this Atrion Corporation Short-Term Incentive Compensation Plan (th
April 8, 2019	DEFA14A	ATRI / ATRION Corp. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
April 8, 2019	DEF 14A	ATRI / ATRION Corp. DEFINITIVE PROXY STATEMENT TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permit
February 26, 2019	10-K	ATRI / ATRION Corp. ANNUAL REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Exact nam
February 26, 2019	EX-99.1	Atrion Reports Results for Fourth Quarter and Full Year 2018 EXHIBIT 99.1 Atrion Reports Results for Fourth Quarter and Full Year 2018 ALLEN, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2018 revenues were $34.9 million compared to $34.0 million in the same period of 2017, net income was $7.7 million compared to $8.6 million in the prior-year period, and diluted earnings per share w
February 26, 2019	EX-21	Subsidiaries of Atrion Corporation As of December 31, 2018 Exhibit 21 Subsidiaries of Atrion Corporation As of December 31, 2018 Subsidiary State ofIncorporation Ownership Atrion Medical Products, Inc. Delaware 100% Halkey-Roberts Corporation Delaware 100% Quest Medical, Inc. Texas 100% AlaTenn Pipeline Company LLC Alabama 100% Atrion Leasing Company LLC Alabama 100%
February 26, 2019	EX-13.1	Atrion Corporation Exhibit 13.1 Company/Index 2013 2014 2015 2016 2017 2018 Atrion Corporation $100.00 $115.79 $130.96 $175.83 $220.29 $260.94 Russell 2000 Index $100.00 $104.89 $100.26 $121.63 $139.44 $124.09 SIC Code Index $100.00 $115.24 $123.26 $143.46 $178.39 $171.03 The graph set forth above compares the total cumulative return for the five-year period ended December 31, 2018 on the Company's common stock, the
February 26, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): February 26, 2019 Atrion Corporation (Exact Name of Registrant as Specified in Charter) DE 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Number)
February 13, 2019	SC 13G	ATRI / ATRION Corp. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* ATRION CORP (Name of Issuer) Common (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S
February 13, 2019	SC 13G	ATRI / ATRION Corp. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* ATRION CORP (Name of Issuer) Common Stock (Title of Class of Securities) 049904105 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
November 9, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 9, 2018 Atrion Corporation (Exact Name of Registrant as Specified in Charter) DELAWARE 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Nu
November 9, 2018	EX-99.1	Atrion Reports Third Quarter Results EXHIBIT 99.1 Atrion Reports Third Quarter Results ALLEN, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced that for the third quarter ended September 30, 2018 revenues totaled $39.3 million, up from $37.9 million for the same period in 2017. Net income for the third quarter of 2018 totaled $9.2 million compared to $8.0 million for the third quarter of 2017,
November 9, 2018	10-Q	ATRI / ATRION Corp. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [ x ] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2018 or [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corp
August 17, 2018	S-8 POS	ATRI / ATRION Corp. S-8 POS As filed with the Securities and Exchange Commission on August 17, 2018 Registration No.
August 17, 2018	S-8 POS	ATRI / ATRION Corp. S-8 POS As filed with the Securities and Exchange Commission on August 17, 2018 Registration No.
August 7, 2018	EX-99.1	Atrion Reports Second Quarter Results EXHIBIT 99.1 Atrion Reports Second Quarter Results ALLEN, Texas, Aug. 07, 2018 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2018 revenues totaled $38.8 million compared with $36.2 million for the same period in 2017. Net income for the second quarter of 2018 totaled $8.8 million as compared to $10.0 million for the same period in 2
August 7, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 7, 2018 Atrion Corporation (Exact Name of Registrant as Specified in Charter) DELAWARE 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Numb
August 7, 2018	10-Q	ATRI / ATRION Corp. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [ x ] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended June 30, 2018 or [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporati
August 7, 2018	EX-10.1	AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN (As last amended on November 7, 2017) Table of Contents Exhibit 10.1 AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN (As last amended on November 7, 2017) Table of Contents ARTICLE 1. DEFINITIONS 1 ARTICLE 2. COMMON STOCK SUBJECT TO PLAN 3 2.1 Common Stock Subject to Plan 3 2.2 Add-back of Grants 3 ARTICLE 3. ELIGIBILITY; GRANTS; AWARD AGREEMENTS 4 3.1 Eligibility 4 3.2 Awards 4 3.3 Provisions Applicable to Section 162(m) 4 3.4 Award
May 23, 2018	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: May 22, 2018 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employer
May 16, 2018	EX-1.01	CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2017 Exhibit 1.01 CONFLICT MINERALS REPORT OF ATRION CORPORATION FOR THE REPORTING PERIOD FROM JANUARY 1 TO DECEMBER 31, 2017 I. Introduction This is the Conflict Minerals1 Report of Atrion Corporation (”we,” “our,” “us,” “Atrion,” or the “Company”) prepared for calendar year 2017 (in accordance with Rule 13p-1 (“Rule 13p-1”) under the Securities Exchange Act of 1934 (the “Act”). Numerous terms in this
May 16, 2018	SD	ATRI / ATRION Corp. SPECIALIZED DISCLOSURE REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 0-10763 63-0821819 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) One Allentown Parkway, Allen, Texas 75002 (Address of principal executive offices)
May 9, 2018	EX-99.1	Atrion Reports First Quarter Results EXHIBIT 99.1 Atrion Reports First Quarter Results ALLEN, Texas, May 09, 2018 (GLOBE NEWSWIRE) - Atrion Corporation (Nasdaq:ATRI) today announced revenues for the quarter ended March 31, 2018 were $39.4 million compared with $38.5 million in the same period in 2017. Net income in the current-year quarter totaled $8.5 million compared to $10.0 million in last year’s first quarter, with diluted earni
May 9, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 9, 2018 Atrion Corporation (Exact Name of Registrant as Specified in Charter) DELAWARE 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 9, 2018	10-Q	ATRI / ATRION Corp. QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [ x ] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended March 31, 2018 or [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corporat
May 9, 2018	EX-10.1	Atrion Corporation Short-Term Incentive Compensation Plan (as last amended on March 12, 2018) (3) EX-10.1 2 atriex101.htm ATRION CORPORATION SHORT-TERM INCENTIVE COMPENSATION PLAN Exhibit 10.1 ATRION CORPORATION SHORT-TERM INCENTIVE COMPENSATION PLAN Effective January 1, 2013 (As last amended on March 12, 2018) ATRION CORPORATION SHORT-TERM INCENTIVE COMPENSATION PLAN Introduction Atrion Corporation (the “Corporation”) adopts this Atrion Corporation Short-Term Incentive Compensation Plan (the
April 9, 2018	DEFA14A	ATRI / ATRION Corp. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant þ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)
April 9, 2018	DEF 14A	ATRI / ATRION Corp. PROXY TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☑ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitte
March 19, 2018	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: March 13, 2018 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employe
March 19, 2018	EX-10.1	Third Amendment to Amended and Restated Employment Agreement for Chairman (8) EX-10.1 3 tv488845ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 THIRD AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS THIRD AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Third Amendment”) is entered into as of the 17th day of March, 2018 by and between Atrion Corporation, a Delaware corporation (the “Company”), and Emile A Battat (the “Executive”). W I T N E S S E T H: WHEREAS, t
March 19, 2018	EX-3.1	Bylaws of Atrion Corporation (as last amended on March 13, 2018) (2) Exhibit 3.1 BYLAWS OF ATRION CORPORATION (As last amended on March 13, 2018) ARTICLE One STOCKHOLDERS MEETINGS 1.01 Fixing Record Date. (a) In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders, or any adjournment thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the
February 27, 2018	EX-99.1	Atrion Reports 2017 Results for Fourth Quarter and Full Year EdgarFiling EXHIBIT 99.1 Atrion Reports 2017 Results for Fourth Quarter and Full Year ALLEN, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ:ATRI) announced today that for the fourth quarter of 2017 revenues were $34.0 million compared to $33.3 million in the same period of 2016, net income was $8.6 million compared to $5.6 million, and diluted earnings per share were $4.66 comp
February 27, 2018	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): February 27, 2018 Atrion Corporation (Exact Name of Registrant as Specified in Charter) DELAWARE 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File N
February 27, 2018	EX-13.1	Atrion Corporation Exhibit 13.1 Company/Index 2012 2013 2014 2015 2016 2017 Atrion Corporation $100.00 $152.72 $176.83 $200.00 $268.53 $336.43 Russell 2000 Index $100.00 $138.82 $145.62 $139.19 $168.85 $193.58 SIC Code Index $100.00 $140.92 $166.14 $176.77 $205.60 $257.98 The graph set forth above compares the total cumulative return for the five-year period ended December 31, 2017 on the Company's common stock, the
February 27, 2018	10-K	ATRI / ATRION Corp. ANNUAL REPORT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2017 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to Commission File Number 001-32982 Atrion Corporation (Exact nam
February 27, 2018	EX-21	Subsidiaries of Atrion Corporation As of December 31, 2017 Exhibit 21 Subsidiaries of Atrion Corporation As of December 31, 2017 Subsidiary State ofIncorporation Ownership Atrion Medical Products, Inc. Delaware 100% Halkey-Roberts Corporation Delaware 100% Quest Medical, Inc. Texas 100% AlaTenn Pipeline Company LLC Alabama 100% Atrion Leasing Company LLC Alabama 100%
November 8, 2017	EX-99.1	Atrion Reports Third Quarter Results EdgarFiling
November 8, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 8, 2017 Atrion Corporation (Exact Name of Registrant as Specified in Charter) DELAWARE 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Nu
November 8, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [ x ] Quarterly Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Quarterly Period Ended September 30, 2017 or [ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Transition Period from to Commission File Number 001-32982 Atrion Corp
November 8, 2017	EX-10.2	Amended and Restated Atrion Corporation 2006 Equity Incentive Plan (as last amended on August 14, 2017) incorporated by reference to Exhibit 10.2 to Atrion Corporation Form 10-Q filed November 8, 2017. EX-10.2 3 atriex102.htm 2006 EQUITY INCENTIVE PLAN Exhibit 10.2 AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN (As last amended on August 14, 2017) AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN Atrion Corporation, a Delaware corporation (the "Company"), has established the Amended and Restated Atrion Corporation 2006 Equity Incentive Plan (the "Plan") for t
November 8, 2017	EX-10.1	Nonqualified Deferred Compensation Plan incorporated by reference to Exhibit 10.1 to Atrion Corporation Form 10-Q filed November 8, 2017. Exhibit 10.1 ATRION CORPORATION NONQUALIFIED DEFERRED COMPENSATION PLAN 1. Establishment of Plan. Atrion Corporation (the “Company”) hereby adopts and establishes this unfunded deferred compensation plan for a select group of key management or highly compensated employees of the Company and its Affiliates which shall be known as the Atrion Corporation Nonqualified Deferred Compensation Plan (the “
August 18, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Date of Report: August 14, 2017 (Date of earliest event reported) Atrion Corporation (Exact name of registrant as specified in its charter) Delaware 001-32982 63-0821819 (State or other jurisdiction (Commission File (I. R. S. Employ
August 8, 2017	EX-99.1	Atrion Reports Second Quarter Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Atrion Reports Second Quarter Results ALLEN, Texas, Aug. 08, 2017 (GLOBE NEWSWIRE) - Atrion Corporation (NASDAQ:ATRI) today announced that for the second quarter ended June 30, 2017 revenues totaled $36.2 million compared with $36.1 million in the same period in 2016. On a diluted per share basis, earnings for the period increased to $5.40 as compare
August 8, 2017	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 8, 2017 Atrion Corporation (Exact Name of Registrant as Specified in Charter) DELAWARE 001-32982 63-0821819 (State or Other Jurisdiction of Incorporation) (Commission File Numb
August 8, 2017	EX-10.2	AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN COMMON STOCK AWARD AGREEMENT Exhibit 10.2 Form of Amended and Restated Common Stock Award Agreement AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN COMMON STOCK AWARD AGREEMENT THIS AWARD AGREEMENT (the "Agreement') is made and entered into as of [DATE] by and between Atrion Corporation, a Delaware corporation (the "Company"), and [NAME OF PARTICIPANT] (the "Participant") pursuant to the Amended and Restate
August 8, 2017	EX-10.4	AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN NON-QUALIFIED STOCK OPTION AWARD AGREEMENT Exhibit 10.4 Form of Amended and Restated Non-Qualified Stock Option Award Agreement AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN NON-QUALIFIED STOCK OPTION AWARD AGREEMENT THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (the "Agreement") is made and entered into effective as of [DATE], by and between Atrion Corporation, a Delaware corporation (the "Company"), and [NAME OF PA
August 8, 2017	EX-10.3	AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT EX-10.3 4 atriex103.htm FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT Exhibit 10.3 Form of Amended and Restated Restricted Stock Unit Award Agreement AMENDED AND RESTATED ATRION CORPORATION 2006 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT THIS AWARD AGREEMENT (the "Agreement") is made and entered into effective as of [DATE] by and between Atrion Corporation, a Delaware corporation

ATRI / Atrion Corporation - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)